(Q35223220)

7 August 2017

1 reference

title

Piroxicam and other cyclooxygenase inhibitors: potential for cancer chemoprevention (English)

1 reference

7 August 2017

Piroxicam and other cyclooxygenase inhibitors: Potential for cancer chemoprevention (English)

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

29 November 2023

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

29 November 2023

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

29 November 2023

author name string

D. L. Earnest

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1305681

11 September 2022

L. J. Hixson

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1305681

11 September 2022

D. S. Alberts

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1305681

11 September 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1305681

11 September 2022

publication date

1 January 1992

1 reference

full work available at URL

7 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fjcb.240501330

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

https://onlinelibrary.wiley.com/doi/full/10.1002/jcb.240501330

29 November 2023

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Journal of Cellular Biochemistry

29 November 2023

published in

1 reference

7 August 2017

16I

1 reference

7 August 2017

156-166

1 reference

Prostaglandin H synthase and xenobiotic oxidation

7 August 2017

1

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Prostaglandin H synthase-dependent mutagenic activation of heterocyclic aromatic amines of the IQ-type.

29 November 2023

3

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Effects of aspirin on 1, 2-dimethylhydrazine-induced colonic carcinogenesis

29 November 2023

7

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

29 November 2023

Cancer Treatment Reports

11

64

1323

Pollard

1980

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Growth inhibition of transplantable murine colon adenocarcinoma 38 by indomethacin

29 November 2023

14

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Evidence that indomethacin reversibly inhibits cell growth in the G1 phase of the cell cycle

29 November 2023

15

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Indomethacin in submicromolar concentrations inhibits cyclic AMP-dependent protein kinase

29 November 2023

17

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

The mechanisms of action of nonsteroidal antiinflammatory drugs

29 November 2023

18

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Immunologic Effects of Nonsteroidal Anti-Inflammatory Drugs

29 November 2023

20

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Prostaglandins and host defense in cancer

29 November 2023

21

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

29 November 2023

Journal of Immunology

22

126

424

Taffert

1981

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

29 November 2023

Journal of Immunology

23

124

2682

Brunda

1980

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Regulation of the immune response by prostaglandins

29 November 2023

24

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Effects of prostaglandins on the spreading, adhesion and migration of mouse peritoneal macrophages

29 November 2023

25

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Enhancement of T lymphocyte proliferative response to mitogens by indomethacin in breast and colorectal cancer patients

29 November 2023

26

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Prostaglandins from tumours of human large bowel

29 November 2023

28

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Patterns of prostaglandin synthesis and degradation in isolated superficial and proliferative colonic epithelial cells compared to residual colon

29 November 2023

30

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

A genetic model for colorectal tumorigenesis

29 November 2023

32

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Treatment of Chemically-Induced Intestinal Cancers with Indomethacin

29 November 2023

34

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Inhibition of initiation and promotion by N-methylnitrosourea-induced colon carcinogenesis in rats by non-steroid anti-inflammatory agent indomethacin.

29 November 2023

36

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Journal of the National Cancer Institute

29 November 2023

37

77

1309

Nigro

1986

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

A protective effect of sulindac against chemically-induced primary colonic tumours in mice.

29 November 2023

38

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Reduction of carcinogenicity of N-nitrosomethylurea by indomethacin and failure of resuming effect of prostaglandin E2 (PGE2) against indomethacin

29 November 2023

40

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Sulindac for polyposis of the colon

29 November 2023

41

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Sulindac for polyposis of the colon.

29 November 2023

42

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Sulindac treatment for familial polyposis coli

29 November 2023

43

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Sulindac causes regression of rectal polyps in familial adenomatous polyposis

29 November 2023

44

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Effects of Long-term Sulindac Therapy on Colonic Polyposis

29 November 2023

45

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

A hypothesis: nonsteroidal anti-inflammatory drugs reduce the incidence of large-bowel cancer.

29 November 2023

47

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Aspirin use and reduced risk of fatal colon cancer

29 November 2023

48

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

The evolution of cancer of the colon and rectum

29 November 2023

49

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Non-steroidal anti-inflammatory drugs and peptic ulcers

29 November 2023

51

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Overview of gastroduodenal mucosal protection

29 November 2023

52

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

Non-steroidal anti-inflammatory drugs and bleeding peptic ulcer

29 November 2023

53

1 reference

https://api.crossref.org/works/10.1002/JCB.240501330

29 November 2023

Identifiers

0 references

1 reference